the timing of the testing of the Russian vaccine against coronavirus may be significantly reduced. This was announced by the head of the laboratory of genomic engineering MIPT Pavel Volchkov, RIA Novosti reported.
As explained Volchkov, usually clinical trials are conducted in three phases and take several years. However, in a pandemic phase, some tests can be reduced at the discretion of the Ministry of health and Rospotrebnadzor. “However, some parameters remain unspecified, for example, the duration of action of the vaccine,” he added.
the Second and third phase trials of the vaccine can do more mass, the specialist explained. In particular, it will apply to medical institutions in clinical trials, but it was the drug still will not. This will help to gather more data on the effects of vaccines concluded Volchkov.
June 18, the first 18 volunteers, we introduced experienced Russian vaccine against coronavirus, developed by the Ministry of defence in cooperation with the National research centre of epidemiology and Microbiology named after academician Gamalei. Later they told that they feel good.
